# EDGAR Filing Document

**Accession Number:** 0001835539
**File Stem:** 0001104659-23-032825
**Filing Date:** 2023-3
**Character Count:** 56957
**Document Hash:** 888898da85979dc6a3bee045f4993efe
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-032825.hdr.sgml**: 20230315

**ACCESSION NUMBER**: 0001104659-23-032825

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230315

**FILED AS OF DATE**: 20230315

**DATE AS OF CHANGE**: 20230315

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Olink Holding AB (publ)
- **CENTRAL INDEX KEY:** 0001835539
- **STANDARD INDUSTRIAL CLASSIFICATION:** LABORATORY ANALYTICAL INSTRUMENTS [3826]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** V7
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40277
- **FILM NUMBER:** 23735703

**BUSINESS ADDRESS:**
- **STREET 1:** UPPSALA SCIENCE PARK
- **CITY:** UPPSALA
- **STATE:** V7
- **ZIP:** SE-751 83
- **BUSINESS PHONE:** 46 (0) 18 444 39 70

**MAIL ADDRESS:**
- **STREET 1:** UPPSALA SCIENCE PARK
- **CITY:** UPPSALA
- **STATE:** V7
- **ZIP:** SE-751 83

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Knilo HoldCo AB
- **DATE OF NAME CHANGE:** 20201208

**UNITED STATES<br> SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**Form 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER**

**PURSUANT TO SECTION 13a-16 OR 15d-16**

**UNDER THE SECURITIES EXCHANGE ACT OF 1934**

**For the month of March 2023**

**Commission File Number: 001-40277**

**OLINK HOLDING AB (PUBL)**<br> (Exact Name of Registrant as Specified in its Charter)

**Uppsala Science Park<br> SE-751 83<br> Uppsala, Sweden**<br> (Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

**Form 20-F ⌧ Form 40-F** **◻**

On March 15, 2023, Olink Holding AB (publ) published its Notice to Attend the Annual General Meeting (the "Notice") which is to be held on April 17, 2023. A copy of the Notice is being furnished as Exhibit 99.1 to this Form 6-K. Materials relating to the Annual General Meeting are available on the Company's website at <u>https://investors.olink.com/annual-general-meeting</u>.

---

| | |
|:---|:---|
| **Exhibit No** **.** | **Description** |
| [99.1](tm239412d1_ex99-1.htm) | [Olink Holding AB (publ) Notice to Attend the Annual General Meeting dated March 15, 2023.](tm239412d1_ex99-1.htm) |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
| **OLINK HOLDING AB (PUBL)** | **OLINK HOLDING AB (PUBL)** |
| By: | /s/ Jon Heimer |
| Name: | Jon Heimer |
| Title: | Chief Executive Officer |

---

Date: March 15, 2023

## Exhibit 99.1

**Exhibit 99.1**

*This is a translation of the Swedish original. In case of any discrepancies between this translation and the Swedish original, the latter shall prevail.*

**Notice to attend the Annual General Meeting of Olink Holding AB (publ)**

**The shareholders of Olink Holding AB (publ) (the "Company" or "Olink"), reg. no. 559189-7755, are hereby given notice to attend the Annual General Meeting to be held at 4:00 p.m. CET on Monday the 17 April 2023, in the Company's facilities at Salagatan 18B, Uppsala. Registration for the meeting commences at 3:30 p.m. CET.**

**NOTICE OF PARTICIPATION**

Shareholders who wish to attend in the proceedings of the Annual General Meeting must:

· be
entered in the share register kept on behalf of the Company by Euroclear Sweden AB, as of Wednesday 5 April 2023; and

&nbsp;&nbsp;&nbsp;&nbsp;· notify the Company's head office at Olink Holding AB (publ), Annual
General Meeting 2023, Uppsala Science Park, SE-751 83 Uppsala, Sweden or by telephone +46 (0)18 444 39 70 or via e-mail to ir@olink.com
no later than Tuesday 11 April 2023. The notification must contain the shareholder's name, social security number (registration
number), address, telephone number and the number of shares represented as well as any attending counsel, maximum two.

Personal data obtained from the share register kept by Euroclear Sweden AB, notices and attendance at the meeting and information on representatives, proxies and assistants will be used for registration, preparation of the voting list for the meeting and, where appropriate, the minutes of the meeting. Personal data is handled in accordance with the Data Protection Regulation (European Parliament and Council Regulation (EU) 2016/679). For full information regarding the Company's handling of personal data, please refer to our privacy policy: https://www.olink.com/about-us/integrity-policy/.

To be entitled to participate in the Meeting a shareholder whose shares are registered in the name of a nominee must, in addition to providing notification of participation, register its shares in its own name so that the shareholder is recorded in the share register on Wednesday 5 April 2023. Such registration may be temporary (so-called voting right registration) and is requested from the nominee in accordance with the nominee's procedures and such time in advance as the nominee determines. Voting right registrations completed not later than Tuesday 11 April 2023 are taken into account when preparing the share register.

The Company intends to enable shareholders to participate electronically via link. It should then be noted that such a procedure presupposes that the Meeting first approves that pre-registered persons participate via link. In the case of participation via link, there is no support for managing the voting register, which means that if participants via a link actively want to influence the Annual General Meeting's decision, this must be done by proxy to a person who physically participates in the Annual General Meeting. If there are registered persons on Tuesday, 11 April 2023 that wish to participate via link, the Company will send out an invitation with instructions on how to join the Annual General Meeting electronically.

**OPPORTUNITY FOR SHAREHOLDERS TO EXERCISE THEIR VOTING RIGHTS THROUGH PROXY** 

Shareholders who do not wish to attend the meeting in person may authorize a proxy to exercise their voting rights. The power of attorney is proposed to be presented to the Chairman of the Meeting or another person whom the shareholder knows will attend the Annual General Meeting. If the power of attorney is exhibited to the Chairman of the Meeting, the power of attorney must be combined with a voting instruction so that the Chairman of the Meeting knows how to vote under the various decision points. If the power of attorney is not combined with a voting instruction, then the Chairman will not be able to represent the shareholder at the meeting. In other cases, the power of attorney should also be combined with a voting instruction. If participation will be by proxy, the shareholder shall issue a written, signed and dated proxy together with any documents verifying authority. Proxies for legal entities must also be accompanied by a certificate of incorporation or equivalent document verifying authority. A copy of the proxy, the voting instruction and any certificate of incorporation should, in advance, before the meeting be sent to the Company at the above address. The original proxy shall, if applicable, also be presented at the meeting. The Company provides the shareholders with proxy forms as well as blank voting instructions, which can be obtained at the Company's head office or on the Company's website www.investors.olink.com by the latest on Wednesday 15 March 2023.

*This is a translation of the Swedish original. In case of any discrepancies between this translation and the Swedish original, the latter shall prevail.*

Note that the possibility of having a proxy exercise the shareholders' voting rights at the Annual General Meeting presupposes that the shareholder has made a notification and is included in the share register in accordance with what is stated above in the Notice of participation. Thus, it is not enough to just submit a power of attorney form.

**PROPOSED AGENDA**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Opening of the Meeting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Election of Chairman to preside over the Meeting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Preparation and approval of Electoral Register.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. Approval of the agenda proposed by the Board.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. Election of one or two persons to approve the Minutes.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. Determination of whether the Meeting has been properly convened.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. Presentation of the Annual report and the Audit Report and the Consolidated Financial Statements and the Consolidated Audit Report.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. Presentation by the CEO.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. Resolutions

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. regarding adoption of the Income Statement and the Balance Sheet and the Consolidated Income Statement and the Consolidated Balance
Sheet,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. regarding allocation of the Company's result in accordance with the duly adopted Balance Sheet, and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. regarding discharge from liability for the members of the Board of Directors and the CEO.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. Report on the work of the Nomination Committee.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. Determination of the number of Board members.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. Resolution of fees for the Board of Directors and the Auditor.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13. Election of Board members and Chairman of the Board of Directors.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14. Election of Auditor.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15. Resolution regarding incentive program ("LTI I 2023").

*This is a translation of the Swedish original. In case of any discrepancies between this translation and the Swedish original, the latter shall prevail.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16. Resolution regarding incentive program ("LTI II 2023").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17. Resolution regarding authorization for the Board of Directors to resolve on a new issue.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18. Closing of the Meeting.

**THE NOMINATION COMMITTEE'S PROPOSED RESOLUTION WITH RESPECT TO ITEMS 2 AND 11-14 ON THE AGENDA**

The Nomination Committee consists of the Chairman of the Board Jon Hindar, Tommi Unkuri (appointed by Summa Equity), Martin Sjölund (appointed by Summa Equity) and Johan Pietilä Holmner (appointed by Summa Equity). Tommi Unkuri is the Chairman of the Nomination Committee. The Nomination Committee, whose members represent 65 per cent of the votes in the Company, has announced the following proposals:

2. Election of Chairman to preside over the Meeting

The Chairman of the Board, Jon Hindar, is proposed as Chairman to preside over the Meeting.

11. Determination of the number of board members

The Nomination Committee proposes that the Board of Directors shall consist of nine board members and one deputy board member.

12. Determination of fees for the Board of Directors and the auditors

The fee for each Board member shall be as follows: USD 120,000 to the Chairman of the Board of Directors, USD 70,000 to each of the other Board members appointed by the Annual General Meeting who are not employed by the Company, additionally USD 20,000 to the Chairman of the Remuneration Committee and additionally USD 10,000 to each other member of the Remuneration Committee, additionally USD 30,000 to the Chairman of the Audit Committee and additionally USD 15,000 to each other member of the Audit Committee. If Tommi Unkuri is elected by the Annual General Meeting, he shall not receive any fees for Board or committee work. Total fees amount to USD 640,000.

Audit fees will be paid according to approved invoices.

**13.** **Election of board members and Chairman of the Board of Directors** 

Re-election of the board members Jon Hindar, Jon Heimer, Solange Bullukian, Johan Lund, Nicolas Roelofs, Mary Reumuth, Robert Schueren and Tommi Unkuri and re-election of Johan Pietilä Holmner as deputy board member.

Dr. Gregory J. Moore is proposed as new board member.

Jon Hindar is proposed to be re-elected as Chairman of the Board of Directors.

Further information about the suggested Board members is available at https://investors.olink.com/annual-general-meeting.

*This is a translation of the Swedish original. In case of any discrepancies between this translation and the Swedish original, the latter shall prevail.*

14. Election of Auditor

The Nomination Committee proposes, in accordance with the recommendation by the Audit Committee that has been approved by the whole Board as a recommendation, that registered auditing firm Ernst & Young AB be re-elected as auditor of the Company until the conclusion of the 2024 Annual General Meeting. Ernst & Young AB has notified that if the Annual General Meeting approves the proposal, authorized public accountant Fredrik Norrman will remain the Auditor in charge.

**PROPOSAL BY THE MAJORITY SHAREHOLDERS WITH RESPECT TO RESOLUTIONS UNDER ITEMS 15**

**15.** **Resolution regarding incentive program ("LTI I 2023")** 

**Background and reasons**

The Company has previously implemented long term incentive programs for the years of 2021 and 2022. In view of this, the majority shareholders propose that the Annual General Meeting resolves to implement a long-term incentive program for the board members in the Company ("**LTI I 2023**"). The proposal to implement an incentive program has been put forward as the majority shareholders determines that it is important and in the interest of all shareholders to create even greater participation for current and future board members in the Company with regard to the group's development. It is also important to encourage continued commitment.

In the light of the above, the majority shareholders propose that the Annual General Meeting resolves to implement the incentive program LTI I 2023 in accordance with item (a)–(b) below. The resolutions under item (a)–(b) below are proposed to be conditional upon each other and for that reason it is proposed that all resolutions are to be passed as one resolution. LTI I 2023 is proposed to include up to 8 current and future board members of the Company.

**Proposal regarding the adoption of LTI I 2023 (item 15 (a))**

LTI I 2023 is comprised of stock options which will be granted to current and future board members of the Company pursuant to the Olink Holding AB (publ) Amended and Restated 2021 Incentive Award Plan (the "**Plan**"), as amended, and an award agreement thereunder to be entered into between the Company and each recipient evidencing each such grant and terms under the Plan. On 14 March 2023, the Board adopted, subject to the approval of the Company's shareholders, an amendment to the Plan, which will become effective on the date of its approval by the Company's shareholders, which will occur upon approval by the Company's shareholders of LTI I 2023 and LTI II 2023 as described herein. The purpose of the amendment to the Plan is to increase the maximum number of shares available for issuance under the Plan in order to ensure that there is a sufficient number of shares available for grant pursuant to LTI I 2023 and LTI II 2023 as described herein.

The majority shareholders propose that the general meeting resolves to issue not more than 70,000 warrants of series I 2023 in order to secure delivery of either shares, warrants of series I 2023 or American depository shares in the Company ("**ADS**") upon exercise of stock options to participants in LTI I 2023. The right to subscribe for the warrants of series I 2023 shall vest in the Company. The Company shall keep warrants of series I 2023 to ensure delivery of shares, warrants of series I 2023 or ADS upon exercise of stock options in LTI I 2023. Each warrant of series I 2023 entitles the holder to subscribe for one (1) share in the Company. The warrants of series I 2023 shall be issued without consideration to the Company.

*This is a translation of the Swedish original. In case of any discrepancies between this translation and the Swedish original, the latter shall prevail.*

Below is a description of the terms and conditions for the LTI I 2023. A copy of the Plan can be found at <u>https://investors.olink.com/annual-general-meeting</u> and shareholders are advised to review the actual terms of the Plan.

***LTI I 2023 – Stock options (with warrants as hedging arrangement)***

 ****

Each stock option entitles the participant to acquire either one (1) share in the Company, one (1) warrant of series I 2023 or one (1) ADS in accordance with the following terms and conditions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Stock options may be granted to current and future board members of the Company;

· The
stock options of LTI I 2023 will be granted without consideration no later than the day before the next Annual General Meeting;

· Each stock option entitles the holder to
 acquire either one (1) share, warrant of series I 2023 or ADS in the Company at an exercise price equal to 100 per cent to the fair
 market value of the share, as determined by the closing price of the Company's ADS on the Nasdaq Global Market on the relevant
 grant date or in the absence of any sale on such date the immediately preceding date on which a sale occurred;

· The
stock options are subject to time-based vesting requirements – on the date when a portion of the options would vest as a result
of the passage of time with the participant remaining a board member of the Olink group;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· The stock options will vest and become exercisable in equal installments
on 7 April 2024, 7 April 2025, 7 April 2026 and 7 April 2027 provided the participant remain a board member of the Olink group at the
applicable vesting dates. As a main rule each vesting period shall be twelve (12) months. All granted stock options will, as a general
rule, have vested (if applicable) on 7 April 2027, i.e, a vesting period of four (4) years. In the event that the period between the grant
date and the first vesting date is less than ten (10) months for any participant, the Board is entitled to decide on a separate vesting
schedule for the participant with conditions substantially equivalent to those set out in this proposed resolution;

· The
stock options may not be transferred or pledged;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Upon vesting, unless the participant's engagement as a board member
ends sooner, stock options remain exercisable for a period of four (4) years from the first vesting date. However, the participants may
only exercise vested stock options during certain exercise windows as set out in separate option agreements; and

· The
terms and conditions for participants in LTI I 2023 granted stock options may differ between countries due to differences in local legislation,
however the terms and conditions shall not be more favorable for participants than what is set out in this resolution proposal.

The warrants issued to the Company in order to secure delivery of shares, warrants of series I 2023 or ADS upon exercise of stock options granted to participants in LTI I 2023 may be exercised for subscription of shares during the period from and during the period commencing on the date of the registration of the issue resolution with the Swedish Companies Registration Office up to and including the date ten (10) years after the registration of the issue resolution with the Swedish Companies Registration Office, at an exercise price equal to the shares' quota value, at the time of exercise.

*This is a translation of the Swedish original. In case of any discrepancies between this translation and the Swedish original, the latter shall prevail.*

**Allocation of stock options, limitations in the disposition over the stock options and the right to receive stock options**

The right to receive stock options of LTI I 2023 shall vest in current and future board members of the Company. In total, a maximum of 70,000 stock options may be granted to participants, of which a maximum of 10,000 stock options may be granted to each participant.

**Proposal regarding issue of warrants of series I 2023 (item 15 (b))**

The majority shareholders proposes that the Company shall issue not more than 70,000 warrants of series I 2023 for subscription of shares, whereby the Company's share capital may be increased by not more than SEK 170,233.46 at full exercise of warrants for subscription of shares, corresponding to approximately 0.06 per cent of the total number of shares and votes in the Company.

The right to subscribe for the warrants of series I 2023 shall, with deviation from the shareholders' preferential rights, only belong to the Company, with the right and obligation to dispose of the warrants of series I 2023 as described above. The subscription for warrants shall be made up to and including 15 May 2023. Each warrant of series I 2023 entitles the holder to subscribe for one (1) share in the Company. The warrants of series I 2023 shall be issued without compensation to the Company.

The warrants may be exercised for subscription of shares during the period from and during the period commencing on the date of the registration of the issue resolution with the Swedish Companies Registration Office up to and including the date ten (10) years after the registration of the issue resolution with the Swedish Companies Registration Office, at an exercise price equal to the shares' quota value, at the time of exercise.

In order to fulfil the commitments arising from LTI I 2023, the majority shareholders proposes that the general meeting authorizes that the Company may assign to a third party or in another way dispose of the warrants of series I 2023 in accordance with above.

A detailed resolution proposal for the issue of warrants of series I 2023, including complete terms and conditions for the warrants is available at www.olink.com.

**Recalculation due to split, consolidation, new share issue etc.**

The exercise price for warrants in LTI I 2023, determined as set out above, shall be rounded to the nearest SEK 0.10 whereby SEK 0.05 shall be rounded upwards. The exercise price and/or the number of shares that each warrant entitles to subscription for may be recalculated in the event of a split or reverse split of shares in accordance with customary re-calculation terms.

**Costs** 

The stock options are expected to incur accounting costs (accounted for in accordance with the accounting standard IFRS 2) as well as social security costs during the term of the stock options. According to IFRS 2, the stock option costs shall be recorded as a personnel expense in the income statement during the vesting period. The total costs for 70,000 stock options, calculated in accordance with IFRS 2, are estimated to amount to approximately SEK 8.8 million during the term of the program (excluding social security costs). The estimated costs have been calculated based on, inter alia, the following assumptions: (i) a market price of the Company's share/ADS of USD 24.11, equivalent to SEK 252.70, at the time of grant, based on a USD-SEK exchange rate of 10.4813, (ii) an estimated future volatility in respect of the Company's share/ADS during the term of the stock options of 71 per cent, (iii) that the maximum number of stock options encompassed by this resolution proposal are granted to participants and (iv) that all granted stock options will vest and be exercised. Social security costs, which are expected to arise primarily in connection with the exercise of stock options, are estimated to amount to approximately SEK 1.3 million during the term of the program, based on inter alia the assumptions set out under items (i)–(iv) above as well as an average social security rate of 15 per cent.

*This is a translation of the Swedish original. In case of any discrepancies between this translation and the Swedish original, the latter shall prevail.*

Other costs related to the LTI I 2023, including inter alia expenses related to fees to external advisors, external appraiser and administration of the incentive program, are estimated to amount to approximately SEK 0.5 million during the term of the program.

Based on the assumptions set out above, the total costs of the LTI I 2023 are estimated to approximately SEK 10.6 million in total during the term of the program. These costs shall be seen in relation to the total employee benefits expenses of the Olink group, which during the financial year 2022 amounted to SEK 721 million.

**Motivation in respect of vesting and exercise conditions** 

According to recommendations laid down by the Swedish Corporate Governance Board (Sw. *Kollegiet för svensk bolagsstyrning*), the vesting period, or the period between the date of grant until the date when a warrant or stock option may be exercised, shall as a general rule not be shorter than three (3) years. As set out further above, stock options will generally vest and become exercisable in equal installments on 7 April for four years (provided that all applicable vesting conditions have then been fulfilled). The reason for applying such terms, which are not in line with the recommendations of the Swedish Corporate Governance Board as set out above, is that the majority shareholders deem such terms to be in line with market practice for stock option programs in most of the countries where the intended participants in the LTI I 2023 are operative. It is therefore, in the opinion of the majority shareholders of the Company, in the best interest of the Company and its shareholders to apply such terms in order to fulfil the objectives of the LTI I 2023.

**Dilution**

Upon exercise of all warrants of series I 2023 issued within the frame of LTI I 2023 for subscription of shares, up to 70,000 shares (with reservation for any re-calculation) may be issued, equivalent to a maximum dilution of approximately 0.06 per cent of the shares and votes of the Company. Upon full exercise of warrants of series I 2023 for subscription of shares, the Company's share capital will increase with SEK 170,233.46. The dilution calculations have been based on the maximum number of shares and votes which may be issued upon exercise of the stock options, divided by the total number of outstanding shares and votes in the Company as per 28 February 2023 after such issues.

**Preparation of the proposal**

The proposal to the incentive program LTI I 2023 has been prepared by the majority shareholders together with external advisers. No participant of LTI I 2023 has participated in the preparation of this proposal.

*This is a translation of the Swedish original. In case of any discrepancies between this translation and the Swedish original, the latter shall prevail.*

**The reason for the deviation from the shareholders' preferential rights**

The reason for the deviation from the shareholders' preferential rights is to implement an incentive program for the Board of Directors in the Company.

**Majority requirement**

A resolution to approve the present proposal is valid only where supported by shareholders holding not less than nine-tenths (9/10) of both the shares voted for and of the shares represented at the general meeting.

**Authorization**

It is further proposed that the Board of Directors, or a person appointed by the Board of Directors, is authorized to undertake such minor adjustments in the decision that may be required for the registration with the Swedish Companies Registration Office and Euroclear Sweden AB and that the Board of Directors shall have the right to undertake minor adjustments to the LTI I 2023 and the Plan due to applicable foreign rules and laws.

**PROPOSAL BY THE BOARD OF DIRECTORS WITH RESPECT TO RESOLUTIONS UNDER ITEMS 9b AND 16-17**

9b. Resolution with respect to disposition of the Company's result according to the adopted Balance Sheet

The Board of Directors proposes that no dividend be paid for the financial year 2022 and that the Company's available funds be capitalized in a new account.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16. Resolution regarding incentive program ("LTI II 2023" - Stock options and restricted stock units (with warrants as a hedging
arrangement))

**Background and reasons**

**The Company has previously implemented long term incentive programs for the years of 2021 and 2022. In view of this, the Board of Directors proposes that the Annual General Meeting resolves to implement a long term incentive program for the members of the group management, key employees, other employees and consultants in the Company and within the group ("LTI II 2023"). The proposal to implement an incentive program has been put forward as the Board of Directors determines that it is important and in the interest of all shareholders to create even greater participation for current and future members of the group management, key employees and other employees and consultants in the Company and the group with regard to the group's development. It is also important to encourage continued employment and service.**

In the light of the above, the Board of Directors proposes that the Annual General Meeting resolves to implement the incentive program LTI II 2023 in accordance with item (a)–(b) below. The resolutions under item (a)–(b) below are proposed to be conditional upon each other and for that reason it is proposed that all resolutions are to be passed as one resolution. LTI II 2023 is proposed to include up to approximately 668 current and future members of the group management, key employees, other employees and consultants within the Olink group.

*This is a translation of the Swedish original. In case of any discrepancies between this translation and the Swedish original, the latter shall prevail.*

**Proposal regarding the adoption of LTI II 2023 (item 16 (a))**

**LTI II 2023 is comprised of stock options and restricted stock units ("RSU") which will be granted to current and future members of the group management, key employees, employees and consultants within the Olink group pursuant to the Plan, as amended, and an award agreement thereunder to be entered into between the Company and each recipient evidencing each such grant and terms under the Plan. On 14 March 2023, the Board adopted, subject to the approval of the Company's shareholders, an amendment to the Plan, which will become effective on the date of its approval by the Company's shareholders, which will occur upon approval by the Company's shareholders of LTI I 2023 and LTI II 2023 as described herein. The purpose of the amendment to the Plan is to increase the maximum number of shares available for issuance under the Plan in order to ensure that there is a sufficient number of shares available for grant pursuant to LTI I 2023 and LTI II 2023 as described herein.**

**The Board of Directors proposes that the general meeting resolves to issue not more than 910,000 warrants of series II 2023 in order to secure delivery of either shares, warrants of series II 2023 or ADS in the Company upon exercise of stock options or RSUs to participants in LTI II 2023. The right to subscribe for the warrants of Series II 2023 shall vest in the Company. The Company shall keep warrants of Series II 2023 to ensure delivery of shares, warrants of series II 2023 or ADS upon exercise of stock options in LTI II 2023. Each warrant of series II 2023 entitles the holder to subscribe for one (1) share in the Company. The warrants of series II 2023 shall be issued without consideration to the Company.**

Below is a description of the terms and conditions for the LTI II 2023. A copy of the Plan can be found at <u>https://investors.olink.com/annual-general-meeting</u> and shareholders are advised to review the actual terms of the Plan.

***LTI II 2023 – Stock options (with warrants as hedging arrangement)***

Each stock option entitles the participant to acquire either one (1) share in the Company, one (1) warrant of series II 2023 or one (1) ADS in accordance with the following terms and conditions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Stock options may be granted to current and future members
of the group management, key employees, other employees and consultants within the Olink group;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· The stock options of LTI II 2023 will be granted without
consideration no later than the day before the next Annual General Meeting;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Each stock option entitles the holder to acquire either one (1) share, warrant of series II 2023 or ADS in the Company at an exercise price equal to 100 per cent to the fair market value
of the share, as determined by the closing price of the Company's ADS on the Nasdaq Global Market on the relevant grant date or
in the absence of any sale on such date the immediately preceding date on which a sale occurred;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· The stock options are subject to time based vesting
requirements – on the date when a portion of the options would vest as a result of the passage of time with the participant remaining
employed or engaged by the Olink group;

*This is a translation of the Swedish original. In case of any discrepancies between this translation and the Swedish original, the latter shall prevail.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· The stock options will vest and become exercisable in
equal installments on 7 April 2024, 7 April 2025, 7 April 2026 and 7 April 2027 provided the participant remain employed or engaged by
the Olink group at the applicable vesting dates. As a main rule each vesting period shall be twelve (12) months. All granted stock options
will, as a general rule, have vested (if applicable) on 7 April 2027, i.e, a vesting period of four (4) years. In the event that the period
between the grant date and the first vesting date is less than ten (10) months for any participant, the Board is entitled to decide on
a separate vesting schedule for the participant with conditions substantially equivalent to those set out in this proposed resolution;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· The stock options may not be transferred or pledged;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Upon vesting, unless the participants engagement as
members of the group management, key employees, other employees and consultants within the Olink group ends sooner, stock options remain
exercisable for a period of four (4) years from the first vesting date. However, the participants may only exercise vested stock options
during certain exercise windows as set out in separate option agreements; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· The terms and conditions for participants in LTI II
2023 granted stock options may differ between countries due to differences in local legislation, however the terms and conditions shall
not be more favorable for participants than what is set out in this resolution proposal.

***LTI II 2023 – Restricted stock units (with warrants as hedging arrangement)***

Within the scope of LTI II 2023, the Company may also grant participants RSUs, entailing the right to, subject to certain conditions being met, receive either a share, warrant of series II 2023 or an ADS free of charge or to an exercise price equal to the quota value of the Company´s share, at the time of exercise of the RSU.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· RSUs may be granted to current and future members of
the group management, key employees, other employees and consultants within the Olink group;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· The RSUs will be granted without consideration no later
than the day before the next Annual General Meeting;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· The RSUs granted will be subject to time based vesting
requirements – on the date when a portion of the RSUs would vest as a result of the passage of time with the participant remaining
employed or engaged by the Olink group;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· The
RSUs will vest in equal installments on 7 April 2024, 7 April 2025, 7 April 2026 and 7 April 2027 provided the participant remain employed
or engaged by the Olink group at the applicable vesting dates and the holders of RSUs will receive a share, ADS or warrant of series
LTI II 2023 in settlement of the RSUs following the applicable vesting date. As a main rule each vesting period shall be twelve (12)
months. All granted RSUs will, as a general rule, have vested (if applicable) on 7 April 2027, i.e, a vesting period of four (4) years.
In the event that the period between the grant date and the first vesting date is less than ten (10) months for any participant, the
Board is entitled to decide on a separate vesting schedule for the participant with conditions substantially equivalent to those set
out in this proposed resolution;

*This is a translation of the Swedish original. In case of any discrepancies between this translation and the Swedish original, the latter shall prevail.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· The RSUs may not be transferred or pledged; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· The terms and conditions for participants in LTI II
2023 granted RSUs may differ between countries due to differences in local legislation, however the terms and conditions shall not be
more favorable for participants than what is set out in this resolution proposal.

The warrants issued to the Company in order to secure delivery of shares, warrants of series II 2023 or ADS upon exercise of stock options or settlement of RSUs granted to participants in LTI II 2023 may be exercised for subscription of shares during the period from and during the period commencing on the date of the registration of the issue resolution with the Swedish Companies Registration Office up to and including the date ten (10) years after the registration of the issue resolution with the Swedish Companies Registration Office, at an exercise price equal to the shares' quota value, at the time of exercise.

**Allocation of stock options and RSUs, limitations in the disposition over the stock options and the RSUs and the right to receive stock options and RSUs**

The participants' right to be granted stock options and RSUs have been differentiated with reference to position, responsibility and working performance in the group and the participants have for this reason been divided into four different categories:

Category A (Management) – Members of the group management;

Category B (Tier I) – Key employees;

Category C (Tier II) – Other employees and consultants; and

Category D (Tier III) – Other individual contributors

The right to receive stock options or RSUs under LTI II 2023 shall vest in members of the group management, key employees, other employees and consultants employed or engaged by the Company or the group. The following allocation applies to the grant of stock options and RSUs within each category.

---

| | | |
|:---|:---|:---|
|  | **Maximum number of stock<br> options/RSUs for each participant** | **Total number of stock <br> options/RSUs within the category**  |
| **Category A – not more than 11 people** | **15,000/65,000** | **70,000/200,000** |
| **Category B – not more than 27 people** | **0/10,000** | **0/120,000** |
| **Category C – not more than 250 people** | **0/5,000** | **0/370,000** |
| **Category D – not more than 380 people** | **0/2,000** | **0/150,000** |

---

In total, a maximum of 840,000 RSUs and 70,000 stock options may be granted to participants.

In the event that all stock options or RSUs within category A, B or C are not transferred, such non-transferred stock options or RSUs may be offered to participants in another category with less stock options and/or RSUs available for allotment. The maximum number of stock options or RSUs per person within each category as set out above may however not be exceeded for any individual.

*This is a translation of the Swedish original. In case of any discrepancies between this translation and the Swedish original, the latter shall prevail.*

**Proposal regarding issue of warrants of series II 2023 (item 16 (b))**

The Board of Directors proposes that the Company shall issue not more than 910,000 warrants of series II 2023 for subscription of shares, whereby the Company's share capital may be increased by not more than SEK 2,213,035.02 at full exercise of warrants for subscription of shares, corresponding to approximately 0.73 per cent of the total number of shares and votes in the Company.

The right to subscribe for the warrants of series II 2023 shall, with deviation from the shareholders' preferential rights, only belong to the Company, with the right and obligation to dispose of the warrants of series II 2023 as described above. The subscription for warrants shall be made up to and including 15 May 2023. Each warrant of series II 2023 entitles the holder to subscribe for one (1) share in the Company. The warrants of series II 2023 shall be issued without compensation to the Company.

The warrants may be exercised for subscription of shares during the period from and during the period commencing on the date of the registration of the issue resolution with the Swedish Companies Registration Office up to and including the date ten (10) years after the registration of the issue resolution with the Swedish Companies Registration Office, at an exercise price equal to the shares' quota value, at the time of exercise.

In order to fulfil the commitments arising from LTI II 2023, the Board of Directors proposes that the general meeting authorizes that the Company may assign to a third party or in another way dispose of the warrants of series II 2023 in accordance with above.

A detailed resolution proposal for the issue of warrants of series II 2023, including complete terms and conditions for the warrants is available at www.olink.com.

**Recalculation due to split, consolidation, new share issue etc.**

The exercise price for warrants in LTI II 2023, determined as set out above, shall be rounded to the nearest SEK 0.10 whereby SEK 0.05 shall be rounded upwards. The exercise price and/or the number of shares that each warrant entitles to subscription for may be recalculated in the event of a split or reverse split of shares in accordance with customary re-calculation terms

**Costs**

The stock options are expected to incur accounting costs (accounted for in accordance with the accounting standard IFRS 2) as well as social security costs during the term of the stock options. According to IFRS 2, the stock option costs shall be recorded as a personnel expense in the income statement during the vesting period. The total costs for 70,000 stock options, calculated in accordance with IFRS 2, are estimated to amount to approximately SEK 8.8 million during the term of the program (excluding social security costs). The estimated costs have been calculated based on, inter alia, the following assumptions: (i) a market price of the Company's share/ADS of USD 24.11, equivalent to SEK 252.70, at the time of grant, based on a USD-SEK exchange rate of 10.4813, (ii) an estimated future volatility in respect of the Company's share/ADS during the term of the stock options of 71 per cent, (iii) that the maximum number of stock options encompassed by this resolution proposal are granted to participants and (iv) that all granted stock options will vest and be exercised. Social security costs, which are expected to arise primarily in connection with the exercise of stock options, are estimated to amount to approximately SEK 1.3 million during the term of the program, based on inter alia the assumptions set out under items (i)–(iv) above as well as an average social security rate of 15 per cent.

*This is a translation of the Swedish original. In case of any discrepancies between this translation and the Swedish original, the latter shall prevail.*

The RSUs are expected to incur accounting costs (accounted for in accordance with the accounting standard IFRS 2) as well as social security costs during the term of the RSUs. According to IFRS 2, the RSUs costs shall be recorded as a personnel expense in the income statement during the vesting period. The total costs for 840,000 RSUs, calculated in accordance with IFRS 2, are estimated to amount to approximately SEK 212.3 million during the term of the program (excluding social security costs). The estimated costs have been calculated based on, inter alia, the following assumptions: (i) a market price of the Company's share/ADS of USD 24.11, equivalent to SEK 252.7, at the time of grant, based on a USD-SEK exchange rate of 10.4813, (ii) that the maximum number of RSUs encompassed by this resolution proposal are granted to participants, (iii) that all granted RSUs will vest and (iv) that holders of RSUs receive a share, ADS or warrant of series LTI II 2023. Social security costs, which are expected to arise primarily in connection with holders of RSUs receive a share, ADS or warrant of series LTI II 2023, are estimated to amount to approximately SEK 70.1 million during the term of the program, based on inter alia the assumptions set out under items (i)–(iv) above as well as an average social security rate of 23 per cent and an annual increase in the market price of the Company's share/ADS of 15 per cent during the vesting period.

Other costs related to the LTI II 2023, including inter alia expenses related to fees to external advisors, external appraiser and administration of the incentive program, are estimated to amount to approximately SEK 1.5 million during the term of the program.

Based on the assumptions set out above, the total costs of the LTI II 2023 are estimated to approximately SEK 293.9 million in total during the term of the program. These costs shall be seen in relation to the total employee benefits expenses of the Olink group, which during the financial year 2022 amounted to SEK 721 million.

**Motivation in respect of vesting and exercise conditions**

According to recommendations laid down by the Swedish Corporate Governance Board (Sw. *Kollegiet för svensk bolagsstyrning*), the vesting period, or the period between the date of grant until the date when a warrant or stock option may be exercised, shall as a general rule not be shorter than three (3) years. As set out further above, stock options will vest and become exercisable in equal installments on 7 April for four years and RSUs will vest in equal installments on 7 April for four years and holders of RSUs will receive a share, ADS or warrant, provided that all applicable vesting conditions have then been fulfilled. The reason for applying such terms, which are not in line with the recommendations of the Swedish Corporate Governance Board as set out above, is that the Board of Directors of the Company deem such terms to be in line with market practice for stock option programs in most of the countries where the intended participants in the LTI II 2023 are operative. It is therefore, in the opinion of the Board of Directors of the Company, in the best interest of the Company and its shareholders to apply such terms in order to fulfil the objectives of the LTI II 2023.

*This is a translation of the Swedish original. In case of any discrepancies between this translation and the Swedish original, the latter shall prevail.*

**Dilution**

Upon exercise of all warrants of series II 2023 issued within the frame of LTI II 2023 for subscription of shares, up to 910,000 shares (with reservation for any re-calculation) may be issued, equivalent to a maximum dilution of approximately 0.73 per cent of the shares and votes of the Company. Upon full exercise of warrants of series II 2023 for subscription of shares, the Company's share capital will increase with SEK 2,213,035.02. The dilution calculations have been based on the maximum number of shares and votes which may be issued upon exercise of the stock options and RSUs, divided by the total number of outstanding shares and votes in the Company as per 28 February 2023 after such issues.

**Preparation of the proposal**

The proposal to the incentive program LTI II 2023 has been prepared by the Remuneration Committee and the Board of Directors together with external advisers. The Company's board member and CEO Jon Heimer has not participated in the preparations of LTI II 2023.

**The reason for the deviation from the shareholders' preferential rights**

The reason for the deviation from the shareholders' preferential rights is to implement an incentive program for the members of the group management, key employees, other employees and consultants in the Company and the group.

**Majority requirement**

A resolution to approve the present proposal is valid only where supported by shareholders holding not less than nine-tenths (9/10) of both the shares voted for and of the shares represented at the general meeting.

**Authorization** 

It is further proposed that the Board of Directors, or a person appointed by the Board of Directors, is authorized to undertake such minor adjustments in the decision that may be required for the registration with the Swedish Companies Registration Office and Euroclear Sweden AB and that the Board of Directors shall have the right to undertake minor adjustments to the LTI II 2023 and the Plan due to applicable foreign rules and laws.

**Outstanding incentive programs**

The Company does have the following outstanding share-related incentive programs.

**LTI 2021. A general meeting held on 16 March 2021 approved the majority shareholders' proposal regarding an incentive program for board members, members of the group management, key employees, other employees and consultants in the Company and within the group and resolution of issue of not more than 1,085,900 warrants and resolution of approving transfer of warrants. In total, 1,085,900 warrants were subscribed by the Company and 378,547 stock options and 333,601 RSUs have been acquired by or granted to participants. No more stock options or RSUs will be offered out of LTI 2021. The exercise price was set to USD 25 per share. Upon exercise of all stock options and RSUs which have been granted to participants and which have, as of the date of this resolution proposal, not yet been exercised, a maximum of 624,484 shares will be issued in the Company, equivalent to a dilution of approximately 0,50 per cent.**

*This is a translation of the Swedish original. In case of any discrepancies between this translation and the Swedish original, the latter shall prevail.*

**LTI I 2022. A general meeting held on 7 April 2022 approved the majority shareholders' proposal regarding an incentive program for board members in the Company and resolved on an issue of not more than 70,000 warrants and resolution of approving transfer of warrants. In total, 65,625 warrants were subscribed by the Company and 65,625 stock options have been acquired by or granted to participants. No more stock options will be offered out of LTI I 2022. The exercise price was set to USD 17.39 per share. Upon exercise of all stock options which have been granted to participants and which have, as of the date of this resolution proposal, not yet been exercised, a maximum of 65,625 shares will be issued in the Company, equivalent to a dilution of approximately 0.05 per cent.**

**LTI II 2022. A general meeting held on 7 April 2022 approved the board of directors' proposal regarding an incentive program for the members of the group management, key employees, other employees and consultants in the Company and within the group and resolved on an issue of not more than 797,514 warrants and resolution of approving transfer of warrants. In total, 797,514 warrants were subscribed by the Company and 41,448 stock options and 611,460 RSUs have been acquired by or granted to participants. No more stock options or RSUs will be offered out of LTI II 2022. The exercise price was set to USD 17.39 per share. Upon exercise of all stock options and RSUs which have been granted to participants and which have, as of the date of this resolution proposal, not yet been exercised, a maximum of 652,908 shares will be issued in the Company, equivalent to a dilution of approximately 0,52 per cent.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17. Resolution regarding authorization for the Board of Directors to resolve on a new issue

The Board of Directors proposes that the Annual General Meeting resolves to authorize the Board of Directors to, at one or several occasions and for the period up until the next Annual General Meeting, increase the Company's share capital by issuing new shares. Such share issue resolution may be carried out with or without deviation from the shareholders' preferential rights whereby payment can be made in cash and with or without provisions for contribution in kind, set-off or other conditions. The authorization may only be utilized to the extent that it corresponds to a dilution of not more than 20 per cent of the total number of shares based on the number of shares outstanding at the time of the general meeting's resolution on the proposed authorization.

The purpose of the authorization is to increase the financial flexibility of the Company and the general flexibility of the Board of Directors. Should the Board of Directors resolve on an issue with deviation from the shareholders' preferential rights, the reason for this shall be to provide the Company with working capital and/or new owners of strategic importance to the Company and/or to procure capital to finance acquisitions of other companies or operations and/or to procure capital to finance the development of projects and/or to commercialize the Company's products. Upon such deviation from the shareholders' preferential rights, the new issue shall be made at market terms and conditions.

The Board of Directors, the CEO or the person that the Board appoints, shall have the right to make any adjustments in the decision required for registration.

The resolution proposed by the Board of Directors in accordance with item 17 must be approved by shareholders representing not less than two thirds of the votes cast and shares represented at the Annual General Meeting.

*This is a translation of the Swedish original. In case of any discrepancies between this translation and the Swedish original, the latter shall prevail.*

**SHARES AND VOTES**

The Company has issued a total of 124,108,371 shares. The total number of votes is 124,108,371. This information relates to the situation at the time of issuing this notice.

**SHAREHOLDERS RIGHT TO REQUEST INFORMATION** 

Pursuant to Chapter 7, section 32 and 57 of the Swedish Companies Act (Sw. *aktiebolagslagen*), the Board of Directors and the CEO are under a duty to, if any shareholder so requests and the Board of Directors deems that it can be made without material damage to the Company, provide information at the Annual General Meeting, regarding circumstances which may affect the assessment of a matter on the agenda or the Company's economic situation. The duty of disclosure also includes the Company's relationship to other group companies, the consolidated accounts and such circumstances regarding subsidiaries which are set out in the preceding sentence.

**DOCUMENTATION**

Accounting documents, the auditor's report, proposals from the Nomination Committee in accordance with item 2 and 11-14 and the majority shareholders' and Board of Directors' complete proposals in accordance with items 9b, 15, 16 and 17 on the agenda will be available at the Company no later than Monday 27 March 2023 and will be sent to shareholders who so request and provide their postal address. These documents will also be available on the Company's website on the same date. The majority shareholders' proposal, the Nomination Committee's proposals and details of all proposed members of the Board of Directors will be available on the Company's website from the date of issuances of this notice.

Uppsala in March 2023

The Board of Directors

*Olink Holding AB (publ)*